Roman Butler Fullerton & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,841
| Closed | -$1.04M | – | 188 |
|
|
2023
Q1 | $1.04M | Sell |
10,841
-3,796
| -26% | -$363K | 0.52% | 60 |
|
|
2022
Q4 | $1.64M | Buy |
14,637
+2,256
| +18% | +$252K | 0.85% | 28 |
|
|
2022
Q3 | $1.09M | Buy |
12,381
+2,019
| +19% | +$178K | 0.69% | 40 |
|
|
2022
Q2 | $902K | Buy |
+10,362
| New | +$902K | 0.5% | 63 |
|
|
2020
Q3 | – | Sell |
-7,585
| Closed | -$936K | – | 154 |
|
|
2020
Q2 | $936K | Sell |
7,585
-793
| -9% | -$97.9K | 0.67% | 53 |
|
|
2020
Q1 | $708K | Buy |
+8,378
| New | +$708K | 0.62% | 57 |
|